Dessislava Fessenko discusses the moral permissibility of genetic selection for non-disease traits and highlights some of the ultimate considerations that should define it.
Daniel Rosenbaum and Daniel Z. Buchman draw attention to commercial involvement in psychedelic research and to the population health risks associated with this involvement.
Shyanne Dougherty questions the goal and the likely effectiveness of the Alberta UCP government’s supposed “recovery-based” approach to the opioid crisis.


